How might an unmet patient need in metal health concerning memory be satisfied using transcribed session summaries

心理健康状况不佳是我们面临的最大健康问题。历史上的污名、隐私问题和无知导致了阻碍创新的研究系统性资金不足。因此，缺乏一致的系统数据来作为研究和开发新方法(如人工智能技术)的基础。Coopts产品Sylvie是一种可以改善心理健康治疗的潜在解决方案。在Aster基金会的帮助下，Coopts发现，心理健康治疗的服务用户以及服务用户的朋友和家人认为Sylvie可以改善他们的心理健康治疗体验。Sylvie最初的重点是帮助临床医生提高工作效率。服务用户只是作为GDPR影响的副产品获得数据。这个项目的重点是从服务使用者和临床医生的角度，使用设计思维和用户参与来检查使用Sylvie作为精神健康治疗的一部分的影响。我们将与这两组用户探讨三个关键问题：1.设备设计选择(例如形状、大小、颜色、图案和硬件特征)对治疗联盟的影响，目的是设计一种将对该联盟的影响降至最低的设备。如何在不限制数据使用方式的情况下，将一个会话中的数据呈现给两个组。我们发现，服务用户和他们的家人/朋友创造性地建议了他们可能使用数据的各种方法和方式，远远超出了我们对样本量的预期。一个关键的设计目标是鼓励这种适应。同样清楚的是，随着治疗的进展，服务用户可能会喜欢不同的演示。临床医生可能还希望根据各种因素(例如，治疗点、目标等)，以不同方式向服务用户呈现随时间推移的治疗数据。数据可能如何通过时间呈现。这一点很重要，因为服务用户恢复的动机可能是决定结果的最关键因素。我们的研究表明，能够看到Sylvie的进展对于保持动力非常重要，特别是在糟糕的会议之后。我们希望从这个项目中获得的设计、思考、学习和经验教训将在未来很好地为我们服务，因为我们预计这不会是一次性的练习，而是成为公司与服务用户和临床医生接触的组成部分。

Poor mental health is the biggest health problem we face. Historic stigma, privacy concerns and ignorance have resulted in systematic underfunding of research hampering innovation. Consequently, there is an absence of consistent systematic data on which to base research and exploit new approaches e.g., AI techniques. Sylvie, Co-Opts product, is a potential solution that can improve mental health therapies.Co-Opts, with the help from the Aster Foundation, found that service-users, as well as friends and family of service-users in mental health therapies, thought that Sylvie could improve their experience of mental health therapies.Sylvie's initial focus was on helping clinicians' productivity. Service-users were getting the data only as a by-product of GDPR implications. This project's focus is to use design-thinking and user engagement to examine the implications of using Sylvie as part of mental health therapy from service-users and clinicians' perspective. We will explore three key issues with these two groups of users:1. The impact of design choices on the device (e.g. shape, size, colour, patterns and hardware features) on the therapeutic alliance, with the aim to design a device that minimises any impact on this alliance.2. How to present the data from one session to both groups without limiting ways of using the data. We have found that service-users and their family/friends creatively suggested a wide range of approaches and ways they might use the data, far more than we expected for the sample size. A key design objective is to encourage this adaptation. It is also clear that as treatment progresses service-users may prefer different presentations. Clinicians may also wish to present treatment data over time to the service user in different ways, depending on various factors (e.g. treatment points, goals, etc.).3. How the data might be presented through time. This is important because the service-user's motivation to recover is perhaps the most critical factor in determining outcomes. Our research suggests that being able to see the progress on Sylvie is important for maintaining motivation, particularly after poor sessions, for service-users.We expect that the design, thinking, learning, and lessons we will take from this project will serve us well into the future as we do not expect this to be a one-off exercise, but rather become an integral part of the company's engagement with service-users and clinicians.